Cargando…
Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer
EphA2 tyrosine kinase is upregulated in many cancers and correlated with poor survival of patients, including those with endometrial cancer. EphA2-targeted drugs have shown modest clinical benefit. To improve the therapeutic response to such drugs, we performed a high-throughput chemical screen to d...
Autores principales: | Dasari, Santosh K., Joseph, Robiya, Umamaheswaran, Sujanitha, Mangala, Lingegowda S., Bayraktar, Emine, Rodriguez-Aguayo, Cristian, Wu, Yutuan, Nguyen, Nghi, Powell, Reid T., Sobieski, Mary, Liu, Yuan, Chowdhury, Mamur A., Amero, Paola, Stephan, Clifford, Lopez-Berestein, Gabriel, Westin, Shannon N., Sood, Anil K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962847/ https://www.ncbi.nlm.nih.gov/pubmed/36835335 http://dx.doi.org/10.3390/ijms24043915 |
Ejemplares similares
-
Targeting CCR2(+) macrophages with BET inhibitor overcomes adaptive resistance to anti-VEGF therapy in ovarian cancer
por: Wu, Yutuan, et al.
Publicado: (2022) -
EphA5 and EphA6: regulation of neuronal and spine morphology
por: Das, Gitanjali, et al.
Publicado: (2016) -
Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
por: Gajdzis, Malgorzata, et al.
Publicado: (2020) -
Inactivating Mutations of the IK Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy
por: Gao, Chao, et al.
Publicado: (2021) -
Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer
por: Lara, Olivia D., et al.
Publicado: (2020)